Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia)

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy, characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. The new drugs used for treating AML are facing a big challenge, and the candidates include cytotoxic drugs, targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Min, Chen, Baoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933364/
https://www.ncbi.nlm.nih.gov/pubmed/29750014
http://dx.doi.org/10.2147/DDDT.S161199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933364/
https://www.ncbi.nlm.nih.gov/pubmed/29750014
http://dx.doi.org/10.2147/DDDT.S161199

Ejemplares similares